15.80
Biohaven Ltd stock is traded at $15.80, with a volume of 2.29M.
It is down -8.30% in the last 24 hours and up +12.78% over the past month.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.
See More
Previous Close:
$17.23
Open:
$17.55
24h Volume:
2.29M
Relative Volume:
1.05
Market Cap:
$1.67B
Revenue:
-
Net Income/Loss:
$-766.97M
P/E Ratio:
-2.0627
EPS:
-7.66
Net Cash Flow:
$-646.43M
1W Performance:
-0.06%
1M Performance:
+12.78%
6M Performance:
-7.76%
1Y Performance:
-69.29%
Biohaven Ltd Stock (BHVN) Company Profile
Name
Biohaven Ltd
Sector
Industry
Phone
203-404-0410
Address
215 CHURCH STREET, NEW HAVEN, CT
Compare BHVN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
BHVN
Biohaven Ltd
|
15.80 | 1.82B | 0 | -766.97M | -646.43M | -7.66 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Biohaven Ltd Stock (BHVN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-17-25 | Initiated | Citigroup | Buy |
Sep-03-25 | Initiated | Raymond James | Strong Buy |
May-19-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Feb-11-25 | Initiated | Deutsche Bank | Buy |
Sep-16-24 | Initiated | Jefferies | Buy |
Sep-04-24 | Initiated | Bernstein | Outperform |
Jul-24-24 | Initiated | Morgan Stanley | Overweight |
Feb-16-24 | Initiated | RBC Capital Mkts | Outperform |
Feb-06-24 | Initiated | UBS | Buy |
Dec-22-23 | Initiated | H.C. Wainwright | Buy |
Dec-08-23 | Initiated | Robert W. Baird | Outperform |
Jan-24-23 | Initiated | SVB Securities | Outperform |
Jan-04-23 | Initiated | JP Morgan | Overweight |
Dec-02-22 | Initiated | BTIG Research | Buy |
Oct-26-22 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
Oct-12-22 | Initiated | Piper Sandler | Overweight |
Aug-19-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Aug-08-22 | Downgrade | Wedbush | Outperform → Neutral |
May-11-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Oct-19-21 | Resumed | Morgan Stanley | Equal-Weight |
Aug-10-21 | Downgrade | UBS | Buy → Neutral |
Aug-03-21 | Reiterated | Canaccord Genuity | Buy |
Mar-11-21 | Initiated | UBS | Buy |
Dec-15-20 | Initiated | H.C. Wainwright | Buy |
Apr-17-20 | Initiated | Cowen | Outperform |
Feb-10-20 | Downgrade | Oppenheimer | Outperform → Perform |
Feb-06-20 | Initiated | Mizuho | Buy |
Nov-22-19 | Initiated | Wedbush | Outperform |
Jun-25-19 | Reiterated | Canaccord Genuity | Buy |
May-06-19 | Initiated | Goldman | Buy |
Apr-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Mar-04-19 | Reiterated | Needham | Buy |
Jul-03-18 | Reiterated | Needham | Buy |
Jul-02-18 | Reiterated | Needham | Buy |
Apr-05-18 | Downgrade | Barclays | Overweight → Equal Weight |
Feb-22-18 | Reiterated | Canaccord Genuity | Buy |
Dec-15-17 | Initiated | Canaccord Genuity | Buy |
Oct-03-17 | Reiterated | Needham | Buy |
View All
Biohaven Ltd Stock (BHVN) Latest News
Will Biohaven Ltd. stock remain a Wall Street favoriteJuly 2025 Retail & Weekly High Return Opportunities - newser.com
Biohaven Ltd. stock chart pattern explainedCPI Data & Free Community Supported Trade Ideas - newser.com
Will Biohaven Ltd. stock pay special dividends2025 Retail Activity & Weekly High Momentum Picks - newser.com
Will Biohaven Ltd. see short term momentumQuarterly Risk Review & Low Risk High Reward Ideas - newser.com
How to recover losses in Biohaven Ltd. stockQuarterly Market Review & Weekly Return Optimization Plans - newser.com
Biohaven (NYSE:BHVN) Trading 7% HigherStill a Buy? - MarketBeat
Weiss Ratings Reaffirms "Sell (E+)" Rating for Biohaven (NYSE:BHVN) - MarketBeat
Pfizer settles Biohaven kickback case with DOJ for $60M - MSN
Leading vs lagging indicators on Biohaven Ltd. performanceWeekly Trade Review & Capital Protection Trading Alerts - newser.com
Will Biohaven Ltd. Common Shares stock outperform energy sector in 2025Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Should Biohaven's (BHVN) Accelerating Cash Burn and Shorter Runway Require Action From Investors? - simplywall.st
New Haven startup Bexorg uses donated brains to reshape drug discovery - Hartford Business Journal
Biohaven (NYSE:BHVN) Trading Down 4.6%Here's Why - MarketBeat
A Look at Biohaven (BHVN) Valuation as Cash Runway Narrows and Funding Concerns Grow - simplywall.st
Biohaven Ltd.’s volatility index tracking explainedQuarterly Portfolio Summary & Fast Moving Stock Watchlists - newser.com
Biohaven Ltd. stock trend forecastIndex Update & Reliable Intraday Trade Plans - newser.com
Published on: 2025-10-06 07:41:08 - newser.com
Published on: 2025-10-05 05:51:51 - newser.com
Is Biohaven Ltd. Common Shares stock a contrarian opportunityQuarterly Profit Summary & Smart Money Movement Alerts - newser.com
Biohaven Ltd. recovery potential after sell off2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Sentiment analysis tools applied to Biohaven Ltd.2025 Top Gainers & AI Enhanced Trading Alerts - newser.com
Regression analysis insights on Biohaven Ltd. performanceStop Loss & Short-Term High Return Strategies - newser.com
What indicators show strength in Biohaven Ltd.Long Setup & Real-Time Chart Breakout Alerts - newser.com
Is Biohaven Ltd. stock a good choice for value investorsRisk Management & Free Community Consensus Stock Picks - newser.com
Jim Cramer on Biohaven Ltd. (BHVN): “I Think That This is a Buy” - MSN
10 Health Care Stocks With Whale Alerts In Today's Session - Benzinga
Published on: 2025-09-29 05:11:50 - newser.com
Biohaven Ltd Stock (BHVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biohaven Ltd Stock (BHVN) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Car Bruce | Chief Scientific Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
4,750 |
0 |
7,133 |
Gentile Kimberly | SVP, Clinical Operations |
Jan 05 '25 |
Option Exercise |
0.00 |
3,750 |
0 |
99,719 |
Clark George C. | VP, Chief Accounting Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
66,168 |
Buten Matthew | Chief Financial Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
4,250 |
0 |
196,013 |
Coric Vlad | Chief Executive Officer |
Jan 05 '25 |
Option Exercise |
0.00 |
14,250 |
0 |
1,803,409 |
CHILDS JOHN W | Director |
Dec 30 '24 |
Buy |
35.94 |
29,000 |
1,042,393 |
2,368,741 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):